ARCTOSTAPHYLOS UVA-URSI LEAF

ARCTOSTAPHYLOS UVA-URSI LEAF was reported 1541 times

ARCTOSTAPHYLOS UVA-URSI LEAF is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE ABSCESS 1 0.0172
1 BLOOD LACTIC ACID 1 0.0078
2 COLD TYPE HAEMOLYTIC ANAEMIA 1 0.0043
3 TRI-IODOTHYRONINE INCREASED 1 0.0025
4 MULTIPLE DRUG THERAPY 1 0.0013
5 HEPATIC HAEMORRHAGE 1 0.0012
6 CORONARY ARTERY DISSECTION 1 0.0012
7 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
8 ALLERGY TO ANIMAL 1 0.0009
9 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
10 EMOTIONAL POVERTY 1 0.0006
11 HYPOGEUSIA 1 0.0005
12 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
13 PRODUCT LOT NUMBER ISSUE 1 0.0005
14 PATELLA FRACTURE 1 0.0004
15 SEDATION COMPLICATION 1 0.0004
16 LIP BLISTER 1 0.0004
17 CLUMSINESS 1 0.0004
18 HEPATIC NECROSIS 1 0.0003
19 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
20 TENSION HEADACHE 1 0.0002
21 APPLICATION SITE BURN 1 0.0002
22 PHLEBITIS 1 0.0002
23 BRADYPHRENIA 1 0.0002
24 ACUTE HEPATIC FAILURE 2 0.0001
25 NASAL DISCOMFORT 1 0.0001
26 SENSORY LOSS 1 0.0001
27 BLOOD MAGNESIUM DECREASED 1 0.0001
28 GASTROINTESTINAL INFECTION 1 0.0001
29 LACERATION 1 0.0001
30 AUTOIMMUNE DISORDER 1 0.0001
31 HEPATIC FAILURE 3 0.0001
32 FOOT DEFORMITY 1 0.0001
33 SNEEZING 2 0.0001
34 BLOOD CALCIUM DECREASED 1 0.0001
35 SECRETION DISCHARGE 1 0.0001
36 ANOSMIA 1 0.0001
37 MUSCULOSKELETAL CHEST PAIN 1 0.0001
38 SENSORY DISTURBANCE 1 0.0001
39 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
40 ORTHOSTATIC HYPOTENSION 1 0.0001
41 PELVIC PAIN 1 0.0001
42 HEPATIC STEATOSIS 1 0.0001
43 ORAL HERPES 1 0.0001
44 INJECTION SITE WARMTH 1 0.0000
45 LOCALISED INFECTION 1 0.0000
46 CARDIOVASCULAR DISORDER 1 0.0000
47 RESPIRATORY TRACT INFECTION 1 0.0000
48 SEDATION 1 0.0000
49 THROAT TIGHTNESS 1 0.0000
50 TREATMENT NONCOMPLIANCE 2 0.0000
51 FEELING COLD 1 0.0000
52 ACUTE MYOCARDIAL INFARCTION 1 0.0000
53 URINARY INCONTINENCE 1 0.0000
54 LIMB DISCOMFORT 1 0.0000
55 GAIT INABILITY 1 0.0000
56 INJECTION SITE SWELLING 2 0.0000
57 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
58 ABNORMAL BEHAVIOUR 1 0.0000
59 INFLUENZA LIKE ILLNESS 2 0.0000
60 BALANCE DISORDER 2 0.0000
61 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
62 THROAT IRRITATION 1 0.0000
63 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
64 COGNITIVE DISORDER 1 0.0000
65 SWELLING 2 0.0000
66 PRODUCTIVE COUGH 1 0.0000
67 RASH ERYTHEMATOUS 1 0.0000
68 LUNG DISORDER 1 0.0000
69 CHEST DISCOMFORT 2 0.0000
70 DEPRESSED MOOD 1 0.0000
71 RASH PRURITIC 1 0.0000
72 NECK PAIN 1 0.0000
73 URINARY TRACT INFECTION 3 0.0000
74 SWELLING FACE 1 0.0000
75 MOBILITY DECREASED 1 0.0000
76 HOT FLUSH 1 0.0000
77 INJECTION SITE BRUISING 1 0.0000
78 INTENTIONAL PRODUCT MISUSE 1 0.0000
79 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
80 MUSCULOSKELETAL STIFFNESS 1 0.0000
81 COVID-19 2 0.0000
82 OROPHARYNGEAL PAIN 1 0.0000
83 NEUROPATHY PERIPHERAL 1 0.0000
84 MIGRAINE 1 0.0000
85 HEART RATE INCREASED 1 0.0000
86 SINUSITIS 1 0.0000
87 HAEMOGLOBIN DECREASED 1 0.0000
88 OVERDOSE 2 0.0000
89 FALL 3 0.0000
90 DECREASED APPETITE 2 0.0000
91 BACK PAIN 2 0.0000
92 PALPITATIONS 1 0.0000
93 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
94 INFECTION 1 0.0000
95 PAIN IN EXTREMITY 2 0.0000
96 HYPOAESTHESIA 1 0.0000
97 PERIPHERAL SWELLING 1 0.0000
98 PARAESTHESIA 1 0.0000
99 TREMOR 1 0.0000
100 DIZZINESS 3 0.0000
101 URTICARIA 1 0.0000
102 TOXICITY TO VARIOUS AGENTS 1 0.0000
103 MUSCLE SPASMS 1 0.0000
104 NASOPHARYNGITIS 1 0.0000
105 DYSPNOEA 3 0.0000
106 FATIGUE 4 0.0000
107 ALOPECIA 1 0.0000
108 HYPOTENSION 1 0.0000
109 SOMNOLENCE 1 0.0000
110 ARTHRALGIA 2 0.0000
111 CONSTIPATION 1 0.0000
112 INCORRECT DOSE ADMINISTERED 1 0.0000
113 FEELING ABNORMAL 1 0.0000
114 WEIGHT DECREASED 1 0.0000
115 ANXIETY 1 0.0000
116 INJECTION SITE PAIN 1 0.0000
117 ASTHENIA 1 0.0000
118 PRURITUS 1 0.0000
119 NAUSEA 2 0.0000
120 RASH 1 0.0000
121 VOMITING 1 0.0000
122 PAIN 1 0.0000
123 HEADACHE 1 0.0000
124 DIARRHOEA 1 0.0000
125 OFF LABEL USE 1 0.0000
126 DRUG INEFFECTIVE 1 0.0000